Fingolimod (Gilenya ®) in Multiple Sclerosis: bradycardia, atrioventricular blocks and mild effect on the QTc interval. Something to do with the L‐type calcium channel?
This article is protected by copyright. All rights reserved.
Source: Fundamental and Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Sylvie Pilote, Chantale Simard, Benoit Drolet Tags: Original Article Source Type: research
More News: Arrhythmia | Calcium | Cardiac Arrhythmia | Drugs & Pharmacology | Electrocardiogram | Gilenya | Heart | Multiple Sclerosis | Perfusion | Study